ZAI Lab's competitors
ZAI Lab's competitors include Cocrystal Pharma, EyeGate Pharmaceuticals, Cannabics Pharmaceuticals and Acer Therapeutics
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing and commercializing innovative medicines. |  Cocrystal Pharma Cocrystal Pharma focuses on discovering and developing novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. |  EyeGate Pharmaceuticals EyeGate Pharmaceuticals develops medicines to treat eye diseases using non-invasive, iontophoretic drug-delivery system. |  Cannabics Pharmaceuticals Cannabics Pharmaceuticals Inc. is dedicated to the development of personalized anti-cancer and palliative treatments. |  Acer Therapeutics Acer Therapeutics is a biotech company that develops repurposed and reformulated medicines for the treatment of ultra-orphan diseases with significant unmet medical needs. |
Founding Date | Founding Date 2013 | Founding Date 2004 | Founding Date 1998 | Founding Date 2012 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Shanghai, CN HQ Suzhou, CN Chaoyang, CN | Locations Tucker, US HQ Bothell, US | Locations Waltham, US HQ | Locations Bethesda, US HQ | Locations Newton, US HQ |
Employees | Employees 21 | Employees 18 | Employees 11 | Employees 2 | Employees 14 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 183.5 m | Valuation ($) 7 m | Valuation ($) 84.6 m | Valuation ($) 70.5 m |
Facebook likes | Facebook likes N/A | Facebook likes 101 | Facebook likes N/A | Facebook likes N/A | Facebook likes 169 |
Twitter followers | Twitter followers N/A | Twitter followers 444 | Twitter followers N/A | Twitter followers 2.4 k | Twitter followers 167 |
Financial | |||||
Net income | Net income ($37.5m) (FY, 2016) | Net income ($613k) (FY, 2017) | Net income ($13.2m) (FY, 2017) | Net income ($1.9m) (FY, 2017) | Net income ($14.2m) (FY, 2017) |
For sources of this data, please see the company profileDownload Excel